| ■ 영문 제목 : Global Induced Pluripotent Stem Cells (iPSCs) Market Growth (Status and Outlook) 2021-2026 | |
 | ■ 상품코드 : LPI-2201K00066 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 87 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료, 제약 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 인공 다능성 줄기 세포 (iPSC)의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (인간 iPS 세포, 쥐 iPS 세포)와 용도별 시장규모 (학술 연구, 의약품 개발 및 발견, 독성 스크리닝, 재생 의료, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 인공 다능성 줄기 세포 (iPSC) 시장 점유율 - 지역별 인공 다능성 줄기 세포 (iPSC) 시장규모 - 주요지역의 종류별 시장규모 (인간 iPS 세포, 쥐 iPS 세포) - 주요지역의 용도별 시장규모 (학술 연구, 의약품 개발 및 발견, 독성 스크리닝, 재생 의료, 기타) - 미주의 인공 다능성 줄기 세포 (iPSC) 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 인공 다능성 줄기 세포 (iPSC) 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 인공 다능성 줄기 세포 (iPSC) 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 인공 다능성 줄기 세포 (iPSC) 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 인공 다능성 줄기 세포 (iPSC) 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Induced Pluripotent Stem Cells (iPSCs) will have significant change from previous year. By the most conservative estimates of global Induced Pluripotent Stem Cells (iPSCs) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 88 million in 2020. Over the next five years the Induced Pluripotent Stem Cells (iPSCs) market will register a 12.8% CAGR in terms of revenue, the global market size will reach US$ 142.8 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Induced Pluripotent Stem Cells (iPSCs) market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Human iPSCs
Mouse iPSCs
Human iPSCs had a market share of 89.65% in 2019, followed by Mouse iPSCs.
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Others
Academic Research is the largest segment of Induced Pluripotent Stem Cells (iPSCs) application,with a share of 32% in 2019.
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Fujifilm Holding Corporation (CDI)
Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology
ReproCELL
1 Scope of the Report 2 Executive Summary 3 Induced Pluripotent Stem Cells (iPSCs) Market Size by Players 4 Induced Pluripotent Stem Cells (iPSCs) by Regions 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Global Induced Pluripotent Stem Cells (iPSCs) Market Forecast 11 Key Players Analysis 12 Research Findings and Conclusion List of TablesTable 1. Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Human iPSCs Table 3. Major Players of Mouse iPSCs Table 4. Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Type (2020-2026) & ($ Millions) Table 5. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) & ($ Millions) Table 6. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2016-2021) Table 7. Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Application (2016-2021) & ($ Millions) Table 8. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021) & ($ Millions) Table 9. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2016-2021) Table 10. Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Players (2019-2021E) & ($ Millions) Table 11. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Players (2019-2021E) Table 12. Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Products Offered Table 13. Induced Pluripotent Stem Cells (iPSCs) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 14. New Products and Potential Entrants Table 15. Mergers & Acquisitions, Expansion Table 16. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions 2016-2021 & ($ Millions) Table 17. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Regions 2016-2021 Table 18. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2016-2021) & ($ Millions) Table 19. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Country (2016-2021) Table 20. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) & ($ Millions) Table 21. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2016-2021) Table 22. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021) & ($ Millions) Table 23. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2016-2021) Table 24. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2016-2021) & ($ Millions) Table 25. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region (2016-2021) Table 26. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) & ($ Millions) Table 27. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2016-2021) Table 28. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021) & ($ Millions) Table 29. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2016-2021) Table 30. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2016-2021) & ($ Millions) Table 31. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Country (2016-2021) Table 32. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) & ($ Millions) Table 33. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2016-2021) Table 34. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021) & ($ Millions) Table 35. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2016-2021) Table 36. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2016-2021) & ($ Millions) Table 37. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region (2016-2021) Table 38. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) & ($ Millions) Table 39. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2016-2021) Table 40. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021) & ($ Millions) Table 41. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2016-2021) Table 42. Key and Potential Regions of Induced Pluripotent Stem Cells (iPSCs) Table 43. Key Application and Potential Industries of Induced Pluripotent Stem Cells (iPSCs) Table 44. Key Challenges of Induced Pluripotent Stem Cells (iPSCs) Table 45. Key Trends of Induced Pluripotent Stem Cells (iPSCs) Table 46. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 47. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share Forecast by Regions (2021-2026) Table 48. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Type (2021-2026) & ($ Millions) Table 49. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share Forecast by Type (2021-2026) Table 50. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Application (2021-2026) & ($ Millions) Table 51. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share Forecast by Application (2021-2026) Table 52. Fujifilm Holding Corporation (CDI) Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors Table 53. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Offered Table 54. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 55. Fujifilm Holding Corporation (CDI) Main Business Table 56. Fujifilm Holding Corporation (CDI) Latest Developments Table 57. Ncardia Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors Table 58. Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Offered Table 59. Ncardia Main Business Table 60. Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 61. Ncardia Latest Developments Table 62. Sumitomo Dainippon Pharma Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors Table 63. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Offered Table 64. Sumitomo Dainippon Pharma Main Business Table 65. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 66. Sumitomo Dainippon Pharma Latest Developments Table 67. Astellas Pharma Inc Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors Table 68. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Offered Table 69. Astellas Pharma Inc Main Business Table 70. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 71. Astellas Pharma Inc Latest Developments Table 72. Fate Therapeutics, Inc Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors Table 73. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Offered Table 74. Fate Therapeutics, Inc Main Business Table 75. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 76. Fate Therapeutics, Inc Latest Developments Table 77. Pluricell Biotech Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors Table 78. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Offered Table 79. Pluricell Biotech Main Business Table 80. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 81. Pluricell Biotech Latest Developments Table 82. Cell Inspire Biotechnology Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors Table 83. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Offered Table 84. Cell Inspire Biotechnology Main Business Table 85. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 86. Cell Inspire Biotechnology Latest Developments Table 87. ReproCELL Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors Table 88. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product Offered Table 89. ReproCELL Main Business Table 90. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 91. ReproCELL Latest Developments List of Figures Figure 1. Induced Pluripotent Stem Cells (iPSCs) Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type in 2020 Figure 7. Induced Pluripotent Stem Cells (iPSCs) in Academic Research Figure 8. Global Induced Pluripotent Stem Cells (iPSCs) Market: Academic Research (2016-2021) & ($ Millions) Figure 9. Induced Pluripotent Stem Cells (iPSCs) in Drug Development and Discovery Figure 10. Global Induced Pluripotent Stem Cells (iPSCs) Market: Drug Development and Discovery (2016-2021) & ($ Millions) Figure 11. Induced Pluripotent Stem Cells (iPSCs) in Toxicity Screening Figure 12. Global Induced Pluripotent Stem Cells (iPSCs) Market: Toxicity Screening (2016-2021) & ($ Millions) Figure 13. Induced Pluripotent Stem Cells (iPSCs) in Regenerative Medicine Figure 14. Global Induced Pluripotent Stem Cells (iPSCs) Market: Regenerative Medicine (2016-2021) & ($ Millions) Figure 15. Induced Pluripotent Stem Cells (iPSCs) in Others Figure 16. Global Induced Pluripotent Stem Cells (iPSCs) Market: Others (2016-2021) & ($ Millions) Figure 17. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2020 Figure 18. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Player in 2020 Figure 19. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Regions (2016-2021) Figure 20. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size 2016-2021 ($ Millions) Figure 21. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size 2016-2021 ($ Millions) Figure 22. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size 2016-2021 ($ Millions) Figure 23. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size 2016-2021 ($ Millions) Figure 24. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Country in 2020 Figure 25. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type in 2020 Figure 26. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2020 Figure 27. United States Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions) Figure 28. Canada Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions) Figure 29. Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions) Figure 30. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Regions in 2020 Figure 31. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type in 2020 Figure 32. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2020 Figure 33. China Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions) Figure 34. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions) Figure 35. Korea Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions) Figure 36. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions) Figure 37. India Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions) Figure 38. Australia Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions) Figure 39. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Country in 2020 Figure 40. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type in 2020 Figure 41. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2020 Figure 42. Germany Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions) Figure 43. France Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions) Figure 44. UK Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions) Figure 45. Italy Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions) Figure 46. Russia Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions) Figure 47. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region in 2020 Figure 48. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type in 2020 Figure 49. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2020 Figure 50. Egypt Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions) Figure 51. South Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions) Figure 52. Israel Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions) Figure 53. Turkey Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions) Figure 54. GCC Country Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions) Figure 55. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions) Figure 56. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions) Figure 57. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions) Figure 58. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions) Figure 59. United States Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions) Figure 60. Canada Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions) Figure 61. Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions) Figure 62. Brazil Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions) Figure 63. China Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions) Figure 64. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions) Figure 65. Korea Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions) Figure 66. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions) Figure 67. India Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions) Figure 68. Australia Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions) Figure 69. Germany Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions) Figure 70. France Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions) Figure 71. UK Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions) Figure 72. Italy Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions) Figure 73. Russia Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions) Figure 74. Spain Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions) Figure 75. Egypt Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions) Figure 76. South Africa Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions) Figure 77. Israel Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions) Figure 78. Turkey Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions) Figure 79. GCC Country Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions) |
| ※본 조사보고서 [세계의 인공 다능성 줄기 세포 (iPSC) 시장예측 2021년-2026년] (코드 : LPI-2201K00066) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 인공 다능성 줄기 세포 (iPSC) 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |